187 related articles for article (PubMed ID: 32860362)
1. A New Series of 1,3-Dimethylxanthine Based Adenosine A
Rohilla S; Bansal R; Chauhan P; Kachler S; Klotz KN
Curr Drug Discov Technol; 2021; 18(5):e26082020185360. PubMed ID: 32860362
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A
Rohilla S; Bansal R; Kachler S; Klotz KN
Bioorg Chem; 2019 Jun; 87():601-612. PubMed ID: 30933785
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel and Selective Adenosine A
Tian S; Wang X; Li L; Zhang X; Li Y; Zhu F; Hou T; Zhen X
J Chem Inf Model; 2017 Jun; 57(6):1474-1487. PubMed ID: 28463561
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
[TBL] [Abstract][Full Text] [Related]
5. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
[TBL] [Abstract][Full Text] [Related]
6. 5-Substituted 2-benzylidene-1-tetralone analogues as A
Janse van Rensburg HD; Terre'Blanche G; van der Walt MM; Legoabe LJ
Bioorg Chem; 2017 Oct; 74():251-259. PubMed ID: 28881253
[TBL] [Abstract][Full Text] [Related]
7. Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.
Koch P; Brunschweiger A; Namasivayam V; Ullrich S; Maruca A; Lazzaretto B; Küppers P; Hinz S; Hockemeyer J; Wiese M; Heer J; Alcaro S; Kiec-Kononowicz K; Müller CE
Front Chem; 2018; 6():206. PubMed ID: 29998095
[TBL] [Abstract][Full Text] [Related]
8. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K
Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606
[TBL] [Abstract][Full Text] [Related]
9. C2-substituted quinazolinone derivatives exhibit A
Pieterse L; van der Walt MM; Terre'Blanche G
Bioorg Med Chem Lett; 2020 Aug; 30(16):127274. PubMed ID: 32631506
[TBL] [Abstract][Full Text] [Related]
10. 2-Benzylidene-1-Indanone Analogues as Dual Adenosine A1/A2a Receptor Antagonists for the Potential Treatment of Neurological Conditions.
van Rensburg HJ; Legoabe L; Terre'Blanche G; Van der Walt M
Drug Res (Stuttg); 2019 Jul; 69(7):382-391. PubMed ID: 30616250
[TBL] [Abstract][Full Text] [Related]
11. New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A
Falsini M; Ceni C; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Martí Navia A; Volpini R; Colotta V
Bioorg Med Chem Lett; 2020 Jun; 30(11):127126. PubMed ID: 32241719
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.
Wang M; Hou S; Wei Y; Li D; Lin J
PLoS Comput Biol; 2021 Mar; 17(3):e1008821. PubMed ID: 33739970
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Path to Double Knockout: Investigating the Selective Dual-Inhibitory Mechanisms of Adenosine Receptors A1 and A2 by a Novel Methoxy-Substituted Benzofuran Derivative in the Treatment of Parkinson's Disease.
Subair TI; Soremekun OS; Olotu FA; Soliman MES
Cell Biochem Biophys; 2021 Mar; 79(1):25-36. PubMed ID: 33222095
[TBL] [Abstract][Full Text] [Related]
14. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
[TBL] [Abstract][Full Text] [Related]
15. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.
Brunschweiger A; Koch P; Schlenk M; Rafehi M; Radjainia H; Küppers P; Hinz S; Pineda F; Wiese M; Hockemeyer J; Heer J; Denonne F; Müller CE
Bioorg Med Chem; 2016 Nov; 24(21):5462-5480. PubMed ID: 27658798
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological characterization of novel xanthine carboxylate amides as A2A adenosine receptor ligands exhibiting bronchospasmolytic activity.
Yadav R; Bansal R; Rohilla S; Kachler S; Klotz KN
Bioorg Chem; 2016 Apr; 65():26-37. PubMed ID: 26851736
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel 1,3,5-triazine as adenosine A
Masih A; Agnihotri AK; Srivastava JK; Pandey N; Bhat HR; Singh UP
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22659. PubMed ID: 33156955
[TBL] [Abstract][Full Text] [Related]
18. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of five-membered heterocyclic derivatives of istradefylline with comparable pharmacological activity.
Wang Y; Wang H; Xu H; Zheng Z; Meng Z; Xu Z; Li J; Xue M
Chem Biol Drug Des; 2022 Oct; 100(4):534-552. PubMed ID: 35569008
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A
Legoabe LJ; Van der Walt MM; Terre'Blanche G
Chem Biol Drug Des; 2018 Jan; 91(1):234-244. PubMed ID: 28734058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]